Company Email Format Management

Re-Vana Therapeutics

Biotechnology Research United Kingdom 21 employees

Employees: 21
Contacts: 2
Emails: 2
Phones: 2

re-vana.com LinkedIn Crunchbase

Re-Vana Therapeutics Overview

Headquarters: United Kingdom
Phone Number: Available in AeroLeads
Website: re-vana.com
Industry: Biotechnology Research
Employees: 21
Founded: 2016
Funding: 12.1M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

AMD photo-crosslinking biologics drug delivery retinal disease polymers ophthalmology retina specialist sustained release macular degeneration reduced patient burden drug durability

About Re-Vana Therapeutics

Re-Vana Therapeutics is a venture-backed, pioneering therapeutics and ocular drug delivery company developing innovative sustained-release biologics to treat serious retinal diseases. The company’s proprietary photo-crosslinked, biodegradable platform technologies, EyeLief®, EyeLief SD™ and OcuLief®, enable custom delivery of a wide range of therapeutic molecules. Numerous platform capabilities create a therapeutic continuum to expand treatment opportunities through both internal development and external, strategic collaborations. Re-Vana envisions a new industry standard for sustained delivery of biologics to the retina, creating transformative and differentiated treatments for physicians and significantly reducing patient treatment burden.

Re-Vana Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 2; 50.0% coverage

Re-Vana Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Raghu Raj Singh Thakur	Professor in Pharmaceutics, Qub I	Belfast Metropolitan Area, United Kingdom	View
Anna Sumeray	CEO at Virometix		View
Michael J. O'rourke	CEO Re-vana Therapeutics, Global Scot	Tampa, Florida, United States	Email Phone
Patrick Ruane		El Dorado Hills, California, United States	Email Phone